Omniscience Pharmaceuticals Inc.
Executive Summary
A carefully integrated array of genomics, bioinformatics, and advanced cloning methods to identify and control metabolic pathways of microorganisms is the driver behind Omniscience Pharmaceuticals Inc.'s strategy for disovering new antibiotics.